Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer

Autor: Avinash Khadela, Vivek P. Chavda, Shruti Soni, Kaivalya Megha, Aanshi J. Pandya, Lalitkumar Vora

Publikováno v: Khadela, A, Chavda, V P, Soni, S, Megha, K, Pandya, A J & Vora, L 2022, ' Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer ', Cancers, vol. 15, no. 1, 233 . https://doi.org/10.3390/cancers15010233

Triple-negative tumors are progressively delineating their existence over the extended spectrum of breast cancers, marked by intricate molecular heterogeneity, a low overall survival rate, and an unexplored therapeutic approach. Although the basal su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::475fe75e084607084fdb86c6b8db50e8
https://pure.qub.ac.uk/en/publications/9ed6c5ec-a4dd-41ca-9d66-553177b1e293

Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects

Autor: Avinash Khadela, Shruti Soni, Kaivalya Megha, Aayushi C. Shah, Aanshi J. Pandya, Nirjari Kothari, Ishika Shah, C. B. Avinash

Publikováno v: Medical oncology (Northwood, London, England). 40(1)

Triple negative breast cancer (TNBC) portraying deficient expression of estrogen receptor (ER), progesterone receptor (PR) and Human epidermal growth factor receptor 2 (HER2) is known to be the most aggressive subtype associated with poor prognosis a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e8e4ae8ea713b375b3eaf955e41c75
https://pubmed.ncbi.nlm.nih.gov/36520261